인쇄하기
취소

US NIH allocates additional funding to develop pyrimidinedione product as an anti-HIV drug

Published: 2011-09-22 06:56:00
Updated: 2011-09-22 06:56:00
The US based ImQuest Pharmaceuticals Inc., a strategic partner of Samjin Pharmaceutical Co., has rectntly received an additional funding of $2.3 million from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV.

The NIH grant provides funding for the cont...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.